title: [The role of thrombolysis in the clinical management of deep vein thrombosis].
abstract: Acute Deep Venous Thrombosis (DVT) therapies have been judged primarily on their ability to prevent symptomatic pulmonary embolism, early thrombus progression, and recurrent VTE. The cornerstones of current management of DVT, supported by the 2008 American College of Chest Physicians (ACCP) guidelines, are the routine use of anticoagulant therapy, graduated elastic compression stockings, and early ambulation. For selected appropriate patients with extensive acute proximal DVT, while the French recommendations (Afssaps 2009) still consider thrombolysis not indicated, ACCP guidelines now suggest in-situ thrombolysis in addition to anticoagulation to reduce the risk of subsequent postthrombotic syndrome (PTS) and recurrent DVT (Grade 2 B recommendation). Contemporary invasive endovascular treatments, called pharmacomechanical treatment, mitigate the drawbacks (major bleeding) historically associated with systemic thrombolytic approaches, by means of intra-thrombus delivery of drugs, followed by mechanical dispersion to accelerate lysis and then aspiration of remaining drug and clot debris. The proof of concept for the "open vein" hypothesis - that a strategy of early thrombus removal can reduce the incidence of PTS long term - comes incrementally and randomized trials (ATTRACT trial with a 2016 target completion date) are currently under way and might lead to a shift of the paradigms of the management of acute DVT focused on active thrombus removal.
authors.affiliation: Pôle Cardiovasculaire Interventionnel, Hôpital Privé d'Antony, 25 rue de la providence, 92160 Antony, France. j.marc.pernes@wanadoo.fr
authors.forename: J-M
authors.initials: JM
authors.lastname: Pernès
mesh_terms: D000208:Acute Disease; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005602:France; D006801:Humans; D061185:Mechanical Thrombolysis / Q000379:methods / Q000639:trends; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D015912:Thrombolytic Therapy / Q000379:methods / Q000639:trends; D020246:Venous Thrombosis / Q000150:complications / Q000628:therapy*
chemical_list: D005343:Fibrinolytic Agents